REGENXBIO, Inc. (RGNX)
11.16
-0.44
(-3.79%)
USD |
NASDAQ |
Jan 30, 16:00
11.10
-0.06
(-0.54%)
After-Hours: 20:00
REGENXBIO Shareholders Equity (Quarterly) : 161.45M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Omeros Corp. | -220.48M |
| Sarepta Therapeutics, Inc. | 1.320B |
| AbbVie, Inc. | -2.642B |
| CytomX Therapeutics, Inc. | 107.39M |
| Krystal Biotech, Inc. | 1.138B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 525.20M |
| Total Liabilities (Quarterly) | 363.75M |
| Debt to Equity Ratio | 1.661 |
| Current Ratio | 2.665 |
| Net Debt Paydown Yield | -4.48% |